Type 2-low asthma phenotypes by integration of sputum transcriptomics and serum proteomics.
Author(s)
Type
Journal Article
Date Issued
2021-01
Date Acceptance
2020-08-20
Citation
Allergy, 2021, 76 (1), pp.380-383
ISSN
0105-4538
Publisher
John Wiley and Sons
Start Page
380
End Page
383
Journal / Book Title
Allergy
Volume
76
Issue
1
Copyright Statement
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. This is the accepted version of the following article: Zounemat Kermani, N., Saqi, M., Agapow, P., Pavlidis, S., Kuo, C., Tan, K.S., Mumby, S., Sun, K., Loza, M., Baribaud, F., Sousa, A.R., Riley, J., Wheelock, A.M., Wheelock, C.E., De Meulder, B., Schofield, J., Sánchez‐Ovando, S., Simpson, J.L., Baines, K.J., Wark, P.A., Auffray, C., Dahlen, S.‐E., Sterk, P.J., Djukanovic, R., Adcock, I.M., Guo, Y.‐k., Chung, K.F. and (2020), Type 2‐low asthma phenotypes by integration of sputum transcriptomics and serum proteomics. Allergy, which has been published in final form at https://doi.org/10.1111/all.14573
Sponsor
Commission of the European Communities
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/32865817
Grant Number
115010
Subjects
asthma
bioinformatics
endotypes
precision medicine
systems biology
Publication Status
Published
Coverage Spatial
Denmark
Date Publish Online
2020-08-31